Showing results (61-70 of 82) with videos related to

Sort By:
Pageof 9
JCI Insight|October 10, 2024
High-dimensional analysis of NK cells in kidney transplantation uncovers subsets associated with antibody-independent graft dysfunctionDan Fu Ruan, Miguel Fribourg, Yuko Yuki, et al.
Nature Immunology|June 1, 2023
HLA class I signal peptide polymorphism determines the level of CD94/NKG2-HLA-E-mediated regulation of effector cell responsesZhansong Lin, Arman A Bashirova, Mathias Viard, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|June 10, 2015
Adaptive Natural Killer Cell and Killer Cell Immunoglobulin-Like Receptor-Expressing T Cell Responses are Induced by Cytomegalovirus and Are Associated with Protection against Cytomegalovirus Reactivation after Allogeneic Donor Hematopoietic Cell TransplantationZachary B Davis, Sarah A Cooley, Frank Cichocki, et al.
European Urology|July 6, 2019
Fibroblast Growth Factor Receptor 3 Alterations and Response to PD-1/PD-L1 Blockade in Patients with Metastatic Urothelial CancerLi Wang, Yixuan Gong, Abdel Saci, et al.
Journal of Human Immunity|February 26, 2026
Human ISG15 deficiency unveils impaired healing of ulcerations via type I interferon-mediated fibrosisChristos Sazeides, Lorenzo Cuollo, Ikjot Sidhu, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 10, 2021
Myeloid Cell-associated Resistance to PD-1/PD-L1 Blockade in Urothelial Cancer Revealed Through Bulk and Single-cell RNA SequencingLi Wang, John P Sfakianos, Kristin G Beaumont, et al.
Blood Advances|April 10, 2020
Diversity of peripheral blood human NK cells identified by single-cell RNA sequencingSamantha L Smith, Philippa R Kennedy, Kevin B Stacey, et al.
Blood Advances|June 16, 2023
Allelic variation of KIR and HLA tunes the cytolytic payload and determines functional hierarchy of NK cell repertoiresCamille Philippon, Sudan Tao, Dennis Clement, et al.
Cell Reports|May 18, 2017
The Intergenic Recombinant HLA-B∗46:01 Has a Distinctive Peptidome that Includes KIR2DL3 LigandsHugo G Hilton, Curtis P McMurtrey, Alex S Han, et al.
Cell Reports|March 2, 2022
SARS-CoV-2 Nsp13 encodes for an HLA-E-stabilizing peptide that abrogates inhibition of NKG2A-expressing NK cellsQuirin Hammer, Josefine Dunst, Wanda Christ, et al.
Pageof 9